J.‐Y. Delattre

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20

Tjeerd J. Postma, Neil K. Aaronson, Jan J. Heimans et al. · European Journal of Cancer · 2005 · 559 citations · Full text

Quality Of Life, Health Sciences, Pain Medicine +11

<i>IDH1</i> or <i>IDH2</i> mutations predict longer survival and response to temozolomide in low-grade gliomas

Caroline Houillier, X. Wang, Gentian Kaloshi et al. · Neurology · 2010 · 528 citations

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

I. Rojas, Francesc Graus, Florence Keime-Guibert et al. · Neurology · 2000 · 321 citations

Temozolomide for low-grade gliomas

Gentian Kaloshi, Alexandra Benouaich‐Amiel, Fousseny Diakité et al. · Neurology · 2007 · 283 citations · Full text

Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Khê Hoang‐Xuan, Luc Taillandier, Olivier Chinot et al. · Journal of Clinical Oncology · 2003 · 262 citations